MSCMX
Price
$17.95
Change
+$0.15 (+0.84%)
Updated
Sep 4 closing price
Net Assets
1.55B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

MSCMX vs RGEBX

Header iconMSCMX vs RGEBX Comparison
Open Charts MSCMX vs RGEBXBanner chart's image
Morgan Stanley Insight C
Price$17.95
Change+$0.15 (+0.84%)
VolumeN/A
Net Assets1.55B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
MSCMX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MSCMX vs. RGEBX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSCMX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. MSCMX (1.55B). MSCMX pays higher dividends than RGEBX: MSCMX (1.18) vs RGEBX (0.00). MSCMX was incepted earlier than RGEBX: MSCMX (10 years) vs RGEBX (11 years). MSCMX (1.90) is less costly to investors than RGEBX (1.09). MSCMX is a more actively managed with annual turnover of: 44.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than MSCMX: RGEBX (250) vs MSCMX (1000). MSCMX annual gain was more profitable for investors over the last year : 73.82 vs. RGEBX (17.59). RGEBX return over 5 years is better than : 38.71 vs. MSCMX (-62.01).
MSCMXRGEBXMSCMX / RGEBX
Total Expense Ratio1.901.09174%
Annual Report Gross Expense Ratio1.901.09174%
Fund Existence10 years11 years-
Gain YTD23.45315.398152%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.55B332B0%
Annual Yield % from dividends1.180.00-
Returns for 1 year73.8217.59420%
Returns for 3 years1.9557.613%
Returns for 5 years-62.0138.71-160%
Returns for 10 years-35.3091.44-39%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
DOCS69.340.82
+1.20%
Doximity
SNDA25.80-0.03
-0.12%
Sonida Senior Living
CETX0.89N/A
-0.12%
Cemtrex In